← All stories
Markets
Argent BioPharma: Has A Global Cannabinoid Licence Deal Redrawn The Story This Week?
Highlights Worldwide commercialisation rights to the lead cannabinoid candidate have been licensed out. Consideration was structured through forgiveness of convertible debt rather than cash. The company retains a share of net revenue from w…
Covered by 1 outlet
All coverage · 1 article